Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 4
1985 5
1986 11
1987 12
1988 3
1989 10
1990 8
1991 4
1992 13
1993 13
1994 9
1995 15
1996 13
1997 12
1998 20
1999 19
2000 25
2001 30
2002 50
2003 43
2004 47
2005 65
2006 71
2007 90
2008 118
2009 164
2010 192
2011 208
2012 239
2013 268
2014 332
2015 353
2016 341
2017 419
2018 463
2019 509
2020 615
2021 712
2022 890
2023 854
2024 555

Text availability

Article attribute

Article type

Publication date

Search Results

6,995 results

Results by year

Filters applied: . Clear all
Page 1
Pan-cancer proteogenomics expands the landscape of therapeutic targets.
Savage SR, Yi X, Lei JT, Wen B, Zhao H, Liao Y, Jaehnig EJ, Somes LK, Shafer PW, Lee TD, Fu Z, Dou Y, Shi Z, Gao D, Hoyos V, Gao Q, Zhang B. Savage SR, et al. Among authors: fu z. Cell. 2024 Jun 17:S0092-8674(24)00583-X. doi: 10.1016/j.cell.2024.05.039. Online ahead of print. Cell. 2024. PMID: 38917788 Free article.
Exceptional-point-enhanced phase sensing.
Mao W, Fu Z, Li Y, Li F, Yang L. Mao W, et al. Among authors: fu z. Sci Adv. 2024 Apr 5;10(14):eadl5037. doi: 10.1126/sciadv.adl5037. Epub 2024 Apr 5. Sci Adv. 2024. PMID: 38579005 Free PMC article.
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
Zhu X, Fu Z, Dutchak K, Arabzadeh A, Milette S, Steinberger J, Morin G, Monast A, Pilon V, Kong T, Adams BN, Prando Munhoz E, Hosein HJB, Fang T, Su J, Xue Y, Rayes R, Sangwan V, Walsh LA, Chen G, Quail DF, Spicer JD, Park M, Dankort D, Huang S. Zhu X, et al. Among authors: fu z. Cancer Res. 2024 Apr 15;84(8):1333-1351. doi: 10.1158/0008-5472.CAN-23-1749. Cancer Res. 2024. PMID: 38277141
mRNA-Laden Lipid-Nanoparticle-Enabled in Situ CAR-Macrophage Engineering for the Eradication of Multidrug-Resistant Bacteria in a Sepsis Mouse Model.
Tang C, Jing W, Han K, Yang Z, Zhang S, Liu M, Zhang J, Zhao X, Liu Y, Shi C, Chai Q, Li Z, Han M, Wang Y, Fu Z, Zheng Z, Zhao K, Sun P, Zhu D, Chen C, Zhang D, Li D, Ni S, Li T, Cui J, Jiang X. Tang C, et al. Among authors: fu z. ACS Nano. 2024 Jan 23;18(3):2261-2278. doi: 10.1021/acsnano.3c10109. Epub 2024 Jan 11. ACS Nano. 2024. PMID: 38207332
A transcription factor atlas of directed differentiation.
Joung J, Ma S, Tay T, Geiger-Schuller KR, Kirchgatterer PC, Verdine VK, Guo B, Arias-Garcia MA, Allen WE, Singh A, Kuksenko O, Abudayyeh OO, Gootenberg JS, Fu Z, Macrae RK, Buenrostro JD, Regev A, Zhang F. Joung J, et al. Among authors: fu z. Cell. 2024 Jun 6;187(12):3161. doi: 10.1016/j.cell.2024.04.038. Epub 2024 May 2. Cell. 2024. PMID: 38697106 Free article. No abstract available.
Single-Atom-Based Nanoenzyme in Tissue Repair.
Fu Z, Fan K, He X, Wang Q, Yuan J, Lim KS, Tang JN, Xie F, Cui X. Fu Z, et al. ACS Nano. 2024 May 21;18(20):12639-12671. doi: 10.1021/acsnano.4c00308. Epub 2024 May 8. ACS Nano. 2024. PMID: 38718193 Review.
Programmability empowering quantum boson sampling.
Fu Z, Bao J, Wang J. Fu Z, et al. Nat Comput Sci. 2023 Oct;3(10):819-820. doi: 10.1038/s43588-023-00534-y. Nat Comput Sci. 2023. PMID: 38177759 No abstract available.
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study.
Ma Y, Huang Y, Zhao Y, Zhao S, Xue J, Yang Y, Fang W, Guo Y, Han Y, Yang K, Li Y, Yang J, Fu Z, Chen G, Chen L, Zhou N, Zhou T, Zhang Y, Zhou H, Liu Q, Zhu Y, Zhu H, Xiao S, Zhang L, Zhao H. Ma Y, et al. Among authors: fu z. Lancet Oncol. 2024 Jul;25(7):901-911. doi: 10.1016/S1470-2045(24)00159-1. Epub 2024 May 29. Lancet Oncol. 2024. PMID: 38823410 Clinical Trial.
6,995 results